NDRA ENDRA Life Sciences Inc.
Nasdaq · SEC CIK 1681682 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 48 since 2021-08-27, latest 2026-03-04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Jacroux Richard | CFO | — | — |
| Basenese Lou | Dir | — | — |
| Harsh Michael | Dir | — | — |
| Tokman Alexander Y | CEO, Dir | — | — |
| DIGIANDOMENICO ANTHONY | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | NDRA | Tokman Alexander Y | CEO, Dir | A - Grant | $0.00 | +26.9K | 101.9K | +36% | $0 | |
| 2026-03-04 | 2026-03-02 | NDRA | Jacroux Richard | CFO | A - Grant | $0.00 | +13.5K | 33.5K | +67% | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | Harsh Michael | Dir | A - Grant | $0.00 | +60.3K | 65.7K | +1,120% | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | Basenese Lou | Dir | A - Grant | $0.00 | +60.3K | 65.7K | +1,120% | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | Tokman Alexander Y | CEO, Dir | A - Grant | $0.00 | +75.0K | 75.0K | +1,500,000% | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | Jacroux Richard | CFO | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2026-01-23 | 2026-01-21 | NDRA | DIGIANDOMENICO ANTHONY | Dir | A - Grant | $0.00 | +60.3K | 136.6K | +79% | $0 | |
| D | 2025-10-15 | 2025-10-10 | NDRA | DIGIANDOMENICO ANTHONY | Dir | A - Grant | $7.06 | +70.8K | 76.3K | +1,301% | +$500.0K |
| 2025-07-01 | 2025-06-11 | NDRA | Basenese Lou | Dir | A - Grant | $0.00 | +5,384 | 5,385 | +538,400% | $0 | |
| 2025-07-01 | 2025-06-11 | NDRA | Harsh Michael | Dir | A - Grant | $0.00 | +5,384 | 5,386 | +269,200% | $0 | |
| 2025-07-01 | 2025-06-11 | NDRA | DIGIANDOMENICO ANTHONY | Dir | A - Grant | $0.00 | +5,384 | 5,443 | +9,125% | $0 | |
| AI | 2024-09-05 | 2024-08-27 | NDRA | UBS Group AG | Market maker, broker-dealer | P - Purchase | — | 0 | 146.0K | New | — |
| I | 2024-08-29 | 2024-08-27 | NDRA | UBS Group AG | 10% | P - Purchase | $0.55 | +3,715 | 146.0K | +3% | +$2,043 |
| 2023-05-22 | 2023-05-18 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $1.65 | +15.0K | 34.1K | +78% | +$24.8K | |
| D | 2023-05-03 | 2023-05-02 | NDRA | DIGIANDOMENICO ANTHONY | Dir | P - Purchase | $1.20 | +83.3K | 102.4K | +436% | +$100.0K |
| 2022-12-13 | 2022-12-09 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $3.40 | +1,500 | 19.1K | +9% | +$5,100 | |
| 2022-11-28 | 2022-11-23 | NDRA | Tokman Alexander Y | Dir | P - Purchase | $0.17 | +10.0K | 162.9K | +7% | +$1,700 | |
| 2022-08-24 | 2022-08-22 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $0.27 | +20.0K | 352.8K | +6% | +$5,400 | |
| 2022-08-24 | 2022-08-22 | NDRA | Tokman Alexander Y | Dir | P - Purchase | $0.26 | +20.0K | 152.9K | +15% | +$5,200 | |
| 2022-05-31 | 2022-05-26 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $0.21 | +25.0K | 332.8K | +8% | +$5,250 | |
| 2022-05-23 | 2022-05-18 | NDRA | Thornton Michael Milos | CTO | P - Purchase | $0.22 | +25.0K | 307.8K | +9% | +$5,500 | |
| 2022-05-19 | 2022-05-17 | NDRA | Michelon Francois Roger | CEO, Dir | P - Purchase | $0.19 | +5,100 | 97.2K | +6% | +$969 | |
| 2022-05-17 | 2022-05-16 | NDRA | Tokman Alexander Y | Dir | P - Purchase | $0.2 | +100.0K | 132.9K | +304% | +$20.0K | |
| 2021-09-22 | 2021-01-28 | NDRA | Thornton Michael Milos | CTO | A - Grant | $0.00 | +22.8K | 316.5K | +8% | $0 | |
| M | 2021-08-27 | 2021-08-25+ | NDRA | Basenese Lou | Dir | S - Sale | $1.83 | -50.0K | 54.1K | -48% | -$91.6K |
Purchase Sale Sale after option exercise All abbreviations